异动解读 | 投行下调目标价致使Apellis Pharmaceuticals盘中股价大跌5.05%

异动解读
04 Mar

生物科技公司Apellis Pharmaceuticals(APLS)今日盘中股价大幅下挫,引发市场密切关注。

投行高盛(GS)下调了该公司的股票目标价,成为该股大跌的主要推手。高盛将Apellis Pharmaceuticals的目标价由之前的36美元下调至32美元,但维持中性投资评级不变。

作为分析师报告下调目标价的主要原因尚未透露,但投资者担心公司增长前景或盈利能力未达预期,导致股票遭到抛售。Apellis Pharmaceuticals盘中一度下跌逾5%,市值蒸发数亿美元。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10